INFLUENCE OF PHENOBARBITAL ON DISPOSITION OF CLONAZEPAM AND ANTIPYRINE IN DOG

被引：20

作者：

BEKERSKY, I

MAGGIO, AC

MATTALIANO, V

BOXENBAUM, HG

MAYNARD, DE

COHN, PD

KAPLAN, SA

机构：

[1] HOFFMANN LA ROCHE INC, DEPT BIOCHEM DRUG METAB, NUTLEY, NJ 07110 USA

[2] HOFFMANN LA ROCHE INC, DEPT MED RES, NUTLEY, NJ 07110 USA

来源：

JOURNAL OF PHARMACOKINETICS AND BIOPHARMACEUTICS | 1977年 / 5卷 / 05期

关键词：

D O I：

10.1007/BF01061731

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

页码：507 / 512

页数：6

共 20 条

[1]

ANTON AH, 1960, J PHARMACOL EXP THER, V129, P282

[2]

BAKKE OM, 1974, ACTA PHARMACOL TOX, V35, P91

[3] PHARMACOKINETICS OF ANTICONVULSANT DRUG CLONAZEPAM EVALUATED FROM SINGLE ORAL AND INTRAVENOUS DOSES AND BY REPEATED ORAL-ADMINISTRATION [J].

BERLIN, A ;

DAHLSTROM, H .

EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1975, 9 (2-3) :155-159

[4] STATISTICAL ESTIMATIONS IN PHARMACOKINETICS [J].

BOXENBAU.HG ;

RIEGELMA.S ;

ELASHOFF, RM .

JOURNAL OF PHARMACOKINETICS AND BIOPHARMACEUTICS, 1974, 2 (02) :123-148

[5] INCREASED CLEARANCE OF ANTIPYRINE AND D-PROPRANOLOL AFTER PHENOBARBITAL TREATMENT IN MONKEY - RELATIVE CONTRIBUTIONS OF ENZYME-INDUCTION AND INCREASED HEPATIC BLOOD-FLOW [J].

BRANCH, RA ;

SHAND, DG ;

WILKINSON, GR ;

NIES, AS .

JOURNAL OF CLINICAL INVESTIGATION, 1974, 53 (04) :1101-1107

[6]

CONNEY AH, 1964, J PHARMACOL EXP THER, V146, P225

[7]

CUCINELL SA, 1965, CLIN PHARMACOL THER, V6, P420

[8]

CUCINELL SA, 1963, J PHARMACOL EXP THER, V141, P157

[9] SERUM CLONAZEPAM CONCENTRATIONS IN CHILDREN WITH ABSENCE SEIZURES [J].

DREIFUSS, FE ;

PENRY, JK ;

ROSE, SW ;

KUPFERBERG, HJ ;

DYKEN, P ;

SATO, S .

NEUROLOGY, 1975, 25 (03) :255-258

[10]

ESCHENHOF E, 1973, ARZNEIMITTELFORSCH, V23, P390

← 1 2 →